KUGELMAN LARRY 4
4 · VALEANT PHARMACEUTICALS INTERNATIONAL · Filed May 13, 2009
Insider Transaction Report
Form 4
KUGELMAN LARRY
Director
Transactions
- Award
Common Stock
2009-05-12+149→ 26,295 total - Award
Common Stock
2009-05-12+6,546→ 32,841 total
Footnotes (2)
- [F1]Represents restricted stock units in lieu of cash for Board and Commitee meeting fees, pursuant to the election of the Board member, which may be settled only in common stock.
- [F2]Represents award of restricted stock units pursuant to the 2006 Equity Incentive Plan, which may be settled only in common stock.